Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (25)
Xia Li, Jin Cheng & Zhiguang Zhou. (2016) Revisiting multiple models of progression of β-cell loss of function in type 1 diabetes: Significance for prevention and cure. Journal of Diabetes 8:4, pages 460-469.
Crossref
Crossref
Jong-Dai Kim, Sung Ju KangMin Kyung LeeSe Eun ParkEun Jung RheeCheol-Young ParkKi-Won OhSung-Woo ParkWon-Young Lee. (2016) C-Peptide-Based Index Is More Related to Incident Type 2 Diabetes in Non-Diabetic Subjects than Insulin-Based Index. Endocrinology and Metabolism 31:2, pages 320.
Crossref
Crossref
M. K. Svensson, M. Tyrberg, L. Nyström, H. J. Arnqvist, J. Bolinder, J. Östman, S. Gudbjörnsdottir, M. Landin-Olsson & J. W. Eriksson. (2015) The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors. Diabetes/Metabolism Research and Reviews 31:2, pages 138-146.
Crossref
Crossref
E. WILDOVÁ, P. DLOUHÝ, P. KRAML, J. RAMBOUSKOVÁ, V. ŠMEJKALOVÁ, J. POTOČKOVÁ & M. ANDĚL. (2013) Orally Administered Whey Proteins Have Comparable Effect on C-Peptide Secretion in Healthy Subjects as Standard C-Peptide Stimulation Tests. Physiological Research, pages 179-186.
Crossref
Crossref
E. Ekholm, A. Gottsäter, L. B. Dahlin & G. Sundkvist. (2011) No signs of progressive beta cell damage during 20 years of prospective follow-up of autoantibody-negative diabetes. Acta Diabetologica 49:1, pages 57-62.
Crossref
Crossref
Hye-Jin YoonYoun-Zoo ChoJi-young KimByung-Joon KimKeun-Young ParkGwan-Pyo KohDae-Ho LeeDong-Mee Lim. (2012) Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients. Diabetes & Metabolism Journal 36:5, pages 379.
Crossref
Crossref
Iain S. Begg, Garth L. Warnock & David M. Thompson. 2012. Visual Dysfunction in Diabetes. Visual Dysfunction in Diabetes
339
365
.
E. Vandemeulebroucke, B. Keymeulen, K. Decochez, I. Weets, C. De Block, F. Féry, U. Van de Velde, I. Vermeulen, P. De Pauw, C. Mathieu, D. G. Pipeleers & F. K. Gorus. (2009) Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients. Diabetologia 53:1, pages 36-44.
Crossref
Crossref
Melanie Rodacki, Adolpho Milech & José Egídio Paulo de Oliveira. (2008) A secreção residual do peptídeo C faz diferença no tratamento do diabetes melito tipo 1?. Arquivos Brasileiros de Endocrinologia & Metabologia 52:2, pages 322-333.
Crossref
Crossref
Ingrid L Mostad, Kristian S Bjerve, Marit R Bjorgaas, Stian Lydersen & Valdemar Grill. (2006) Effects of n−3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. The American Journal of Clinical Nutrition 84:3, pages 540-550.
Crossref
Crossref
B. Berger, H. Borg, P. Fernlund, G. Stenström & G. Sundkvist. (2006) Islet antibodies associated with pancreatic B-cell dysfunction at and 3�years after diagnosis of diabetes in subjects aged 35?64�years old: degree of impairment less severe than in those aged 0?34�years old. Diabetic Medicine 23:11, pages 1180-1185.
Crossref
Crossref
E. Bakhtadze, H. Borg, G. Stenström, P. Fernlund, H. J. Arnqvist, A. Ekbom-Schnell, J. Bolinder, J. W. Eriksson, S. Gudbjörnsdottir, L. Nyström, L. C. Groop & G. Sundkvist. (2006) HLA-DQB1 genotypes, islet antibodies and beta cell function in the classification of recent-onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden. Diabetologia 49:8, pages 1785-1794.
Crossref
Crossref
Gunnar Stenström, Anders Gottsäter, Ekaterine Bakhtadze, Bo Berger & Göran Sundkvist. (2005) Latent Autoimmune Diabetes in Adults. Diabetes 54:suppl_2, pages S68-S72.
Crossref
Crossref
Nicole A. Sherry, Emily B. Tsai & Kevan C. Herold. (2005) Natural History of β-Cell Function in Type 1 Diabetes. Diabetes 54:suppl_2, pages S32-S39.
Crossref
Crossref
Anna Schölin, Agneta Siegbahn, Lars Lind, Christian Berne, Göran Sundkvist, Elisabeth Björk & F. Anders Karlsson. (2004) CRP and IL‐6 concentrations are associated with poor glycemic control despite preserved β‐cell function during the first year after diagnosis of type 1 diabetes. Diabetes/Metabolism Research and Reviews 20:3, pages 205-210.
Crossref
Crossref
A. Scholin, L. Bjorklund, H. Borg, H. Arnqvist, E. Bjork, G. Blohme, J. Bolinder, J. W. Eriksson, S. Gudbjornsdottir, L. Nystrom, J. Ostman, A. F. Karlsson & G. Sundkvist. (2004) Islet antibodies and remaining beta-cell function 8 years after diagnosis of diabetes in young adults: a prospective follow-up of the nationwide Diabetes Incidence Study in Sweden. Journal of Internal Medicine 255:3, pages 384-391.
Crossref
Crossref
Maria Svensson, Göran Sundkvist, Hans J. Arnqvist, Elisabeth Björk, Göran Blohmé, Jan Bolinder, Marianne Henricsson, Lennarth Nyström, Ole Torffvit, Ingeborg Waernbaum, Jan Östman & Jan W. Eriksson. (2003) Signs of Nephropathy May Occur Early in Young Adults With Diabetes Despite Modern Diabetes Management. Diabetes Care 26:10, pages 2903-2909.
Crossref
Crossref
Michael Alvarsson, Göran Sundkvist, Ibe Lager, Marianne Henricsson, Kerstin Berntorp, Eva Fernqvist-Forbes, Lars Steen, Gunilla Westermark, Per Westermark, Thomas Örn & Valdemar Grill. (2003) Beneficial Effects of Insulin Versus Sulphonylurea on Insulin Secretion and Metabolic Control in Recently Diagnosed Type 2 Diabetic Patients. Diabetes Care 26:8, pages 2231-2237.
Crossref
Crossref
Marianne Henricsson, Lennarth Nyström, Göran Blohmé, Jan Östman, Carin Kullberg, Maria Svensson, Anna Schölin, Hans J. Arnqvist, Elisabeth Björk, Jan Bolinder, Jan W. Eriksson & Göran Sundkvist. (2003) The Incidence of Retinopathy 10 Years After Diagnosis in Young Adult People With Diabetes. Diabetes Care 26:2, pages 349-354.
Crossref
Crossref
H. Borg, C. Marcus, S. Sjöblad, P. Fernlund & G. Sundkvist. (2002) Insulin autoantibodies are of less value compared with islet antibodies in the clinical diagnosis of autoimmune type 1 diabetes in children older than 3 yr of age. Pediatric Diabetes 3:3, pages 149-154.
Crossref
Crossref
Henrik Borg, Anders Gottsäter, Per Fernlund & Göran Sundkvist. (2002) A 12-Year Prospective Study of the Relationship Between Islet Antibodies and β-Cell Function At and After the Diagnosis in Patients With Adult-Onset Diabetes. Diabetes 51:6, pages 1754-1762.
Crossref
Crossref
Marianne Henricsson, Kerstin Berntorp, Per Fernlund & Göran Sundkvist. (2002) Progression of Retinopathy in Insulin-Treated Type 2 Diabetic Patients. Diabetes Care 25:2, pages 381-385.
Crossref
Crossref
A. J. Scheen. 1996. Glucagon III. Glucagon III
211
222
.
A. Gottsäter, M. Landin-Olsson, Å. Lernmark, P. Fernlund, G. Sundkvist & W.A. Hagopian. (1995) Glutamate decarboxylase antibody levels predict rate of β-cell decline in adult-onset diabetes. Diabetes Research and Clinical Practice 27:2, pages 133-140.
Crossref
Crossref
A. Gotts�ter, M. Landin-Olsson, �. Lernmark, P. Fernlund & G. Sundkvist. (1994) Islet cell antibodies are associated with?-cell failure also in obese adult onset diabetic patients. Acta Diabetologica 31:4, pages 226-231.
Crossref
Crossref